EN
中文 EN
Pipeline & Strategy
Home >Innovation >Pipeline & Strategy
Pipeline
CanSinoBIO is dedicated in innovation and has established a diversified portfolio of product candidates preventing more than 10 diseases, demonstrating strong competitiveness.
Globally Innovative First-in-class in China Pre-clinical Innovative
Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menhycia® (3 months-6 years old)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT dual vectors) iPneucia®
Groups A and C Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menphecia®
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Convidecia®
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia® Air® and XBB.1.5 VARIANT
Ad5-EBOV
DTcP Infant
Absorbed Tetanus Vaccine
Tdcp Adolescent and Adult
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Indication Expansion (7-59 years old)
Recombinant Poliomyelitis vaccine
PBPV
Recombinant Zoster Vaccine (Adenovirus Vector)
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
Inhaled Tuberculosis Vaccine (Adenovirus Type 5 Vector)
DTcP-Hib-MCV4 Combined Vaccine
24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)
CS-2606 mRNA Multi-valent Influenza Vaccine
CS-2023 Meningococcal vaccine
Other Combined Vaccines
Strategy
The increasing demand for combination vaccines is expected to drive our business growth.
Meningococcal Vaccine Products
  • Groups A and C Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menphecia®
  • Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menhycia®
  • CS-2023 Meningococcal vaccine
Pneumococcal Vaccine Products
  • PCV13i (CRM197/TT Double vector)
  • PBPV
  • CS-2028 Multivalent Pneumococcal Conjugate Vaccine
DTP Vaccine Products
  • DTcP Infant
  • Tdcp Adolescent and Adult
  • DTcP-Hib-MCV4 Combined Vaccine
Other
  • TB Booster
  • Recombinant Zoster Vaccine (Adenovirus Vector)
  • Absorbed Tetanus Vaccine
  • Recombinant Poliomyelitis vaccine
  • Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
Emergency Infectious Diseases Vaccine
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Convidecia®
  • Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia Air® and XBB.1.5 VARIANT
  • Ad5-EBOV